 SANTA MONICA, Calif., May 12, 2021 GLOBE NEWSWIRE -- BioVie Inc. NASDAQ: BIVI BioVie or Company, a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and neuro-degenerative disorders and certain cancers, today announced that it will host a research and development day on Wednesday, May 19, 2021 from 12:00pm 2:00pm Eastern Time. 